FDA Clears Way for Use of Monkeypox Doses in U.S.

The Food and Drug Administration signed off on a Bavarian Nordic A/S monkeypox vaccine plant, a move that allows use in the U.S. of 786,000 doses made at the facility in Denmark.

The FDA said Wednesday it had validated the quality of the shots made at the plant and they met the agency’s standards.